News

1 to 9 of 197 results

Teva 4th-quarter sales and earnings in line with expectations

05-02-2015

Israel-based Teva Pharmaceutical Industries today reported results for the quarter and the year ended…

FinancialGenericsPharmaceuticalPharmaceutical industryTeva Pharmaceutical IndustriesThomson ReutersUnited StatesVideo game development

Teva returns rights to custirsen to OncoGenex

Teva returns rights to custirsen to OncoGenex

31-12-2014

Canada-based OncoGenex Pharmaceuticals saw its shares rise 0.9% to $2.19 on Tuesday, despite announcing…

custirsenLicensingOncoGenexOncologyPharmaceuticalResearchTeva Pharmaceutical Industries

Teva boosted by generics business to generate sales of $5.06 billion in third-qtr

Teva boosted by generics business to generate sales of $5.06 billion in third-qtr

31-10-2014

Israel-based Teva Pharmaceutical Industries generated sales of $5.06 billion in the third quarter of…

FinancialIsraelPharmaceuticalTevaTeva Pharmaceutical Industries

Asthma’s treatment pipeline very strong as more personalized medicines emerge

Asthma’s treatment pipeline very strong as more personalized medicines emerge

26-09-2014

Asthma has a very strong drug pipeline, with almost 100 novel molecules or formulations currently in…

AstraZenecabenralizumabBosatriaCinquilGlaxoSmithKlineGlobalPharmaceuticalResearchRespiratory and PulmonaryTeva Pharmaceutical Industries

Teva to sue Dr Reddy’s over Copaxone patent infringement

Teva to sue Dr Reddy’s over Copaxone patent infringement

08-08-2014

Global generics leader Teva Pharmaceutical Industries yesterday confirmed that it has received the first…

CopaxoneDr Reddy's LaboratoriesLegalNeurologicalPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

EXPERT VIEW: Fewer ‘pay-for-delay’ agreements are likely but they might not disappear altogether

EXPERT VIEW: Fewer ‘pay-for-delay’ agreements are likely but they might not disappear altogether

01-08-2014

The pharmaceutical sector is still reeling from the latest fines imposed by the European Competition…

EuropeEuropean Competition CommissionGenericsInterviewsLegalLupinMylan LaboratoriesPharmaceuticalRegulationServierTeva Pharmaceutical IndustriesUSA

Arena Pharma in deal with Teva unit for marketing Belviq in Israel

Arena Pharma in deal with Teva unit for marketing Belviq in Israel

21-07-2014

USA-based Arena Pharmaceuticals has entered into an exclusive marketing and supply agreement for its…

AbicArena PharmaceuticalsBelviqLicensingMetabolicsObesityPharmaceuticalRegulationRest of the WorldTeva Pharmaceutical Industries

1 to 9 of 197 results

Back to top